Abstract
Treatment with Imatinib is generally well-tolerated, and in the majority of patients side effects are only represented by mild to moderate haematological toxicity (Druker 2001).
However, a wide spectrum of cutaneous reaction related to imatinib administration has been reported in recent literature. In this chapter, a thorough description of cutaneous adverse events related to Imatinib treatment is provided and the pathogenetics hypothesis will be discussed.
| Original language | English |
|---|---|
| Title of host publication | Imatinib: chemical stucture, pharmacology, adverse effects |
| Publisher | Barbara J. Larsen Nova Science Publishers, Hauppauge, NY, AV. |
| Pages | 81-87 |
| Number of pages | 7 |
| Volume | 1 |
| ISBN (Print) | 9781628083040 |
| Publication status | Published - 1 Jan 2014 |
Keywords
- Imatinib mesylate
- melanoma